A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL)

BACKGROUND: Anti‐tumour necrosis factor (TNF) and anti‐interleukin (IL)‐12/23 biologics revolutionized plaque psoriasis treatment by enabling ≥75% improvement in the Psoriasis Area and Severity Index (PASI 75) in clinical trials. Modern biologics are now reported to achieve PASI 100 (complete skin c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Eur Acad Dermatol Venereol
Autori principali: Seneschal, J., Lacour, J.‐P., Bewley, A., Faurby, M., Paul, C., Pellacani, G., De Simone, C., Horne, L., Sohrt, A., Augustin, M., Hammond, E., Reich, K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Psoriasis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7818467/
https://ncbi.nlm.nih.gov/pubmed/32364296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16568
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi